CHTH — CNL Healthcare Properties Income Statement
0.000.00%
Last trade - 00:00- $876.37m
- $1.38bn
- $365.96m
Annual income statement for CNL Healthcare Properties, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 8-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Preliminary |
| Revenue | |||||
| Total Revenue | 295 | 323 | 341 | 366 | 393 |
| Cost of Revenue | |||||
| Gross Profit | 84.9 | 81.1 | 87.8 | 104 | — |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 296 | 305 | 327 | 335 | 359 |
| Operating Profit | -0.177 | 17.2 | 14.7 | 30.9 | 33.8 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -18.7 | 0.128 | -25.1 | -13.8 | -8.11 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -22.9 | -0.412 | -25.7 | -14.4 | — |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -22.9 | -1.45 | -25.7 | -14.5 | — |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -22.9 | -1.45 | -25.7 | -14.5 | — |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.095 | -0.063 | -0.151 | -0.083 | — |